Your browser doesn't support javascript.
loading
Low Level Viremia Is Associated With Serious non-AIDS Events in People With HIV.
Ganesan, Anuradha; Hsieh, Hsing-Chuan; Chu, Xiuping; Colombo, Rhonda E; Berjohn, Catherine; Lalani, Tahaniyat; Yabes, Joseph; Joya, Christie A; Blaylock, Jason; Agan, Brian K.
Afiliação
  • Ganesan A; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Hsieh HC; Division of Infectious Diseases, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Chu X; Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Colombo RE; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Berjohn C; Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Lalani T; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Yabes J; Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Joya CA; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Blaylock J; Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Agan BK; Infectious Disease Service, Madigan Army Medical Center, Tacoma, Washington, USA.
Open Forum Infect Dis ; 11(4): ofae147, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38628953
ABSTRACT

Background:

The consequences of low-level viremia in people with HIV are unclear. We used data from the US Military HIV Natural History Study to examine the association of low-level viremia (LLV) and serious non-AIDS events (SNAEs).

Methods:

Included participants initiated antiretroviral therapy after 1996 and had ≥3 viral loads (VLs) measured, using an assay with a lower limit of detection of <50 copies/mL, ≥6 months after antiretroviral therapy initiation. VLs were categorized as lower levels of LLV (51-199 copies/mL), higher level of low-level viremia (HLLV; 200-999 copies/mL), and (VF; ≥200 copies/mL on 2 or more successive determinations or a single VL ≥1000 copies/mL), and virologic suppression (VS; ie, VL <50 copies/mL). Viral blips (ie, VLs between 50 and 999 copies/mL that are preceded and succeeded by VL <50 copies/mL) were analyzed in the VS category. Cox proportional hazards models were used to examine the association of LLV and SNAEs, adjusted hazard ratios and 95% confidence intervals are presented.

Results:

A total of 439 (17.4%) SNAEs were recorded among the 2528 participants (93% male, 40% Caucasian, 43% African American) followed for a median of 11 years. In 8.5% and 4.6% of the participants, respectively, LLV and HLLV were the highest recorded viremia strata. Compared with VS, SNAEs were associated with LLV (1.3 [1.2-1.4]), HLLV (1.6 [1.5-1.7]), and virologic failure (1.7 [1.7-1.8]).

Conclusions:

The results of this study suggest that LLV is associated with the occurrence of SNAEs and needs further study.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article